When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IDNA - ACADIA: The Company's Perspectives In Numbers.
iShares Genomics Immunology and Healthcare
I treat ACADIA Pharmaceuticals as an attractive long-term investment opportunity based firstly on the demographic trends in the U.S. as well as in the world and secondly on diseases progressing Y/Y for which the company is developing medications.
ACADIA is well prepared financially and has the infrastructure for its new medication with FDA approval upcoming. Its investors can expect to see the company’s sales rise substantially in the short-term and long-term.
About the company
ACADIA Pharmaceuticals (NASDAQ: ACAD) is a U.S. based biopharmaceutical company. It is engaged in the development and production of innovative